Article

Coding and non-coding drivers of mantle cell lymphoma identified through exome and genome sequencing

2019-07-08

Abstract excerpt

Mantle cell lymphoma (MCL) is an uncommon B-cell non-Hodgkin lymphoma (NHL) that is incurable with standard therapies. The genetic drivers of this cancer have not been firmly established and the features known to contribute to differences in clinical course remain limited. To extend our understanding of the biological pathways involved in this malignancy, we performed a large-scale genomic analysis of MCL using da...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 1724643a-bc75-5601-a599-f17949f51201
DOI: 10.1101/686956

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Coding and non-coding drivers of mantle cell lymphoma identified through exome and genome sequencingDOI 10.1101/686956Read

Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing.Semantic proximity Read

Surveying the Genomic Landscape of Mantle Cell Lymphoma Indicates the Importance of Multimodal Genomic and Transcriptomic ExplorationSemantic proximity Read

The genomic landscape of mantle cell lymphoma is related to the epigenetically determined chromatin state of normal B cells.Semantic proximity Read

Landscape of somatic mutations and clonal evolution in mantle cell lymphoma.Semantic proximity Read

Molecular characterization of sorted malignant B cells from patients clinically identified with mantle cell lymphoma.Semantic proximity Read

Activating somatic mutations in diffuse large B-cell lymphomas: lessons from next generation sequencing and key elements in the precision medicine era.Semantic proximity Read

Next generation sequencing and the management of diffuse large B-cell lymphoma: from whole exome analysis to targeted therapy.Semantic proximity Read

Molecular and functional profiling identifies therapeutically targetable vulnerabilities in plasmablastic lymphomaSemantic proximity Read

Biological and clinical determinants shaping heterogeneity in mantle cell lymphomaSemantic proximity Read

Comprehensive genetic analysis by targeted sequencing identifies risk factors and predicts patient outcome in Mantle Cell Lymphoma: results from the EU-MCL network trialsSemantic proximity Read

Genomic landscape and prognostic analysis of mantle cell lymphoma.Semantic proximity Read

Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.Semantic proximity Read